Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes... Show more
CDXS is expected to report earnings to fall 30.77% to -9 cents per share on November 12
Q3'26
Est.
$-0.09
Q2'26
Beat
by $0.01
Q1'26
Beat
by $0.06
Q4'25
Beat
by $0.15
Q3'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -12 cents, beating the estimate of -14 cents. With 1.09M shares outstanding, the current market capitalization sits at 118.27M.